• Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of "Buy" from Brokerages

    Источник: Buzz FX / 27 янв 2025 04:41:18   America/New_York


    Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of "Buy" from Brokerages Written by MarketBeat January 27, 2025 Share Link copied to clipboard. Shares of Corvus Pharmaceuticals, Inc.
    Read more...
Опубликовать